In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

Melina Awar; Eleftherios Mylonakis

doi:10.7326/J23-0039

In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

Ann Intern Med. 2023 Jun;176(6):JC63. doi: 10.7326/J23-0039. Epub 2023 Jun 6.

Authors

Melina Awar¹, Eleftherios Mylonakis¹

Affiliation

¹ Houston Methodist Hospital, Houston, Texas, USA (M.A., E.M.).

PMID: 37276605
DOI: 10.7326/J23-0039

Abstract

Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.

Publication types

Comment

MeSH terms

Aged
Antibodies, Viral
Humans
Respiratory Syncytial Virus Infections* / prevention & control
Respiratory Syncytial Virus Vaccines*
Respiratory Tract Diseases*

Substances

Antibodies, Viral
Respiratory Syncytial Virus Vaccines